Bemis Company, Inc. (BMS) Expected to Post Quarterly Sales of $999.07 Million
Wall Street brokerages expect Bemis Company, Inc. (NYSE:BMS) to announce sales of $999.07 million for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Bemis’ earnings. The highest sales estimate is $1.04 billion and the lowest is $973.00 million. Bemis posted sales of $995.40 million during the same quarter last year, which suggests a positive year over year growth rate of 0.4%. The company is scheduled to issue its next quarterly earnings results on Thursday, April 26th.
On average, analysts expect that Bemis will report full-year sales of $999.07 million for the current financial year, with estimates ranging from $3.96 billion to $4.12 billion. For the next fiscal year, analysts forecast that the business will report sales of $4.09 billion per share, with estimates ranging from $3.96 billion to $4.19 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Bemis.
Bemis (NYSE:BMS) last announced its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.02. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $978.34 million. Bemis had a return on equity of 17.52% and a net margin of 2.32%. The firm’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.67 EPS.
Shares of Bemis (BMS) traded up $1.23 during trading hours on Friday, hitting $45.97. The stock had a trading volume of 1,018,953 shares, compared to its average volume of 675,045. The firm has a market cap of $4,174.31, a P/E ratio of 45.07, a price-to-earnings-growth ratio of 2.34 and a beta of 0.86. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.86 and a quick ratio of 0.93. Bemis has a 12 month low of $40.60 and a 12 month high of $50.47.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Tuesday, February 20th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 2.61%. The ex-dividend date of this dividend is Friday, February 16th. Bemis’s dividend payout ratio (DPR) is presently 117.65%.
Institutional investors have recently modified their holdings of the company. MAI Capital Management purchased a new stake in shares of Bemis in the fourth quarter worth approximately $204,000. Private Trust Co. NA purchased a new stake in shares of Bemis in the fourth quarter worth approximately $205,000. Heartland Advisors Inc. purchased a new stake in shares of Bemis in the third quarter worth approximately $212,000. Janus Henderson Group PLC purchased a new stake in shares of Bemis in the second quarter worth approximately $222,000. Finally, Bbva Compass Bancshares Inc. purchased a new stake in shares of Bemis in the third quarter worth approximately $237,000. 77.32% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This article was originally published by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/bemis-company-inc-bms-expected-to-post-quarterly-sales-of-999-07-million/1874830.html.
Bemis Company Profile
Bemis Company, Inc is a manufacturer of packaging products. The Company operates through two segments: U.S. Packaging and Global Packaging. The U.S. Packaging segment represents all food, consumer, and industrial products packaging-related manufacturing operations located in the United States. The Global Packaging segment includes all packaging-related manufacturing operations located outside of the United States, as well as global medical device and pharmaceutical packaging-related manufacturing operations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bemis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bemis and related companies with MarketBeat.com's FREE daily email newsletter.